|
Delayed
Australian S.E.
17:59:03 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 0.0490 AUD | 0.00% |
|
-7.55% | -19.67% |
| 08-28 | Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 05-13 | Control Bionics Limited Announces Board Changes, Effective May 14, 2026 | CI |
Company Valuation: Control Bionics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 58.04 | 19.56 | 7.872 | 10.36 | 8.838 | 30.49 |
| Change | - | -66.31% | -59.75% | 31.65% | -14.71% | 244.92% |
| Enterprise Value (EV) 1 | 45.71 | 14.57 | 7.008 | 10.27 | 8.601 | 28.95 |
| Change | - | -68.13% | -51.9% | 46.48% | -16.22% | 236.58% |
| P/E | -12.3x | -3.15x | -1.39x | -1.4x | -1.3x | -3.78x |
| PBR | 3.38x | 1.64x | 1.1x | 1.65x | 1.6x | 4.83x |
| PEG | - | -0.1x | 0.1x | 0x | 0x | 0.2x |
| Capitalization / Revenue | 14.2x | 4.06x | 1.4x | 1.94x | 1.44x | 6.4x |
| EV / Revenue | 11.2x | 3.03x | 1.24x | 1.92x | 1.4x | 6.07x |
| EV / EBITDA | -15.3x | -2.55x | -1.44x | -1.99x | -1.67x | -4.83x |
| EV / EBIT | -14.5x | -2.37x | -1.34x | -1.75x | -1.44x | -4.34x |
| EV / FCF | -25x | -2.71x | -2.74x | -3.86x | -3.52x | -9.33x |
| FCF Yield | -4% | -36.9% | -36.5% | -25.9% | -28.4% | -10.7% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0566 | -0.0715 | -0.0624 | -0.0371 | -0.0231 | -0.0196 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 4.088 | 4.815 | 5.642 | 5.351 | 6.145 | 4.767 |
| EBITDA 1 | -2.996 | -5.722 | -4.87 | -5.158 | -5.139 | -5.999 |
| EBIT 1 | -3.149 | -6.139 | -5.235 | -5.882 | -5.957 | -6.663 |
| Net income 1 | -3.551 | -6.101 | -5.631 | -5.914 | -6.109 | -7.266 |
| Net Debt 1 | -12.33 | -4.985 | -0.8632 | -0.0969 | -0.2373 | -1.536 |
| Reference price 2 | 0.6950 | 0.2250 | 0.0870 | 0.0520 | 0.0300 | 0.0740 |
| Nbr of stocks (in thousands) | 83,514 | 86,911 | 90,479 | 199,287 | 294,611 | 411,962 |
| Announcement Date | 8/25/21 | 8/24/22 | 8/30/23 | 8/27/24 | 9/12/25 | 8/27/26 |
1AUD in Million2AUD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 19.05M | |
| 34.96x | 5.97x | 22.82x | 0.27% | 253B | |
| 36.24x | 6.89x | 21.57x | 0.64% | 160B | |
| 50.32x | 12.19x | 26.16x | -.--% | 151B | |
| 18.13x | 3.61x | 11.78x | -.--% | 64.23B | |
| 21.25x | 2.53x | 12.78x | 2.38% | 54.11B | |
| 36.97x | 7.41x | 23.45x | -.--% | 53.76B | |
| 47x | 11.56x | 25.47x | -.--% | 49.71B | |
| 33.51x | 6.64x | 22.56x | 0.6% | 48.49B | |
| 78.69x | 7.5x | 22.76x | -.--% | 44.17B | |
| Average | 39.68x | 7.15x | 21.04x | 0.43% | 87.92B | |
| Weighted average by Cap. | 38.69x | 7.34x | 21.92x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CBL Stock
- Valuation Control Bionics Limited
Select your edition
All financial news and data tailored to specific country editions
